TORONTO, Sept. 3 /CNW/ - Therapure Biopharma Inc., a Canadian
biopharmaceutical company, announced that it is open for business and has its
first contracts with customers in biopharmaceutical development and
Located in Mississauga, Ontario, just 30 minutes from Toronto's Pearson
International Airport, Therapure Biopharma provides clients with customized
solutions for the development and manufacture of complex biological products.
Leveraging its unique and flexible, 130,000 square foot cGMP manufacturing
facility, its extensive quality systems, and the dedication of its highly
experienced staff, Therapure Biopharma is able to develop effective and
innovative solutions to advance therapeutic proteins from the lab to the
"We are more than just a contract manufacturing organization (CMO)," said
Thomas G. Wellner, President and Chief Executive Officer. "The Company's
scientific, manufacturing, and downstream purification expertise, combined
with an intimate understanding of advanced biology, complex proteins, and the
regulatory requirements for biological drugs, enables us to be a drug
development partner with our clients."
Therapure Biopharma offers a wide range of value-added services covering
all aspects of protein production so that the scale-up to commercial
manufacture will not be a barrier to success. The Company's qualified staff
has solved many of the manufacturing challenges facing clients, and the
Company will partner with clients to solve their challenges. Many dynamic
companies have access to novel, high-value protein-based products that are
ready for commercialization but do not have the capabilities to move ahead
alone. Therapure Biopharma can help by applying a deep understanding of the
market and the business opportunities for protein-based therapeutics.
"We understand the complex regulatory processes for the registration of
biological products and have established quality-based cGMP compliant
manufacturing processes. We also understand and appreciate the confidential
nature of your business and desire a long-term relationship," said Mr.
Wellner. "Therapure Biopharma is your one-stop shop for pilot and commercial
scale protein/API production, processing, filling, and finishing. We can
address your scale-up challenges from bench to commercial scale. Partner with
us and we will apply our expertise and proprietary technology to advance your
Let Therapure Biopharma be a partner in bringing your biopharmaceutical
products to the world. For more information, please visit the company's
website at www.therapurebio.com.
For further information:
For further information: Thomas G. Wellner, President and CEO, Tel:
(905) 286-6204, email: firstname.lastname@example.org